Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2.25
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.5 to $2.25.
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.5 to $2.25.